<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Violante S</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>National Institutes of Health</funding><pagination>4355-4364</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6404569</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(3)</volume><pubmed_abstract>Peroxisomes are essential organelles for the specialized oxidation of a wide variety of fatty acids, but they are also able to degrade fatty acids that are typically handled by mitochondria. Using a combination of pharmacological inhibition and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 genome editing technology to simultaneously manipulate peroxisomal and mitochondrial fatty acid β-oxidation (FAO) in HEK-293 cells, we identified essential players in the metabolic crosstalk between these organelles. Depletion of carnitine palmitoyltransferase (CPT)2 activity through pharmacological inhibition or knockout (KO) uncovered a significant residual peroxisomal oxidation of lauric and palmitic acid, leading to the production of peroxisomal acylca</pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.</pubmed_title><pmcid>PMC6404569</pmcid><funding_grant_id>R01DK113172</funding_grant_id><funding_grant_id>R01 DK113172</funding_grant_id><pubmed_authors>Hagen J</pubmed_authors><pubmed_authors>Waterham HR</pubmed_authors><pubmed_authors>Argmann CA</pubmed_authors><pubmed_authors>Achetib N</pubmed_authors><pubmed_authors>Yu C</pubmed_authors><pubmed_authors>Houten SM</pubmed_authors><pubmed_authors>Vaz FM</pubmed_authors><pubmed_authors>Violante S</pubmed_authors><pubmed_authors>van Roermund CWT</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Baes M</pubmed_authors><pubmed_authors>Dodatko T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peroxisomes can oxidize medium- and long-chain fatty acids through a pathway involving ABCD3 and HSD17B4.</name><description>Peroxisomes are essential organelles for the specialized oxidation of a wide variety of fatty acids, but they are also able to degrade fatty acids that are typically handled by mitochondria. Using a combination of pharmacological inhibition and clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 genome editing technology to simultaneously manipulate peroxisomal and mitochondrial fatty acid β-oxidation (FAO) in HEK-293 cells, we identified essential players in the metabolic crosstalk between these organelles. Depletion of carnitine palmitoyltransferase (CPT)2 activity through pharmacological inhibition or knockout (KO) uncovered a significant residual peroxisomal oxidation of lauric and palmitic acid, leading to the production of peroxisomal acylca</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2026-06-04T11:18:16.851Z</modification><creation>2025-06-01T04:03:38.348Z</creation></dates><accession>S-EPMC6404569</accession><cross_references><pubmed>30540494</pubmed><doi>10.1096/fj.201801498R</doi><doi>10.1096/fj.201801498r</doi></cross_references></HashMap>